Search Constraints

Start Over
Filtering by: Study Program Molecular Medicine Study Program (MolMed) Remove constraint Study Program: Molecular Medicine Study Program (MolMed) Subject Outcomes Remove constraint Subject: Outcomes

Search Results

  • Beta-blocker use and hematopoietic stem cell transplant outcomes

    Description/Abstract: Background: While hematopoietic stem cell transplantation (HSCT) is an effective treatment for hematological malignancies, it is associated with several potential complications. Recent studies have associated beta-blocker (BB) use in critical care...
    Date: August 1-2, 2024